Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

GARRELL M

Loffler's syndrome. Report of a case associated with the administration of aurothioglucose (Solganal).

Archives of internal medicine 1960 Dec;106;874-7 — 1960 Dec — 874-7

Podell TE, Klinenberg JR, Kramer LS, Brown HV

Pulmonary toxicity with gold therapy.

Arthritis and rheumatism 1980 Mar;23;347-50 — 1980 Mar — 347-50

Breton JL, Garnier G, Toulouse J, Depierre A

Bronchoalveolar lavage and gold salt-induced pneumonitis.

Chest 1985 Mar;87;410 — 1985 Mar — 410

Limpisvasti P, Jones P

Report of a case: gold-associated pulmonary injury.

Hawaii medical journal 1979 Feb;38;43-5 — 1979 Feb — 43-5